The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches von Macaluso, Fabio Salvatore, Fries, Walter, Viola, Anna, Centritto, Andrea, Cappello, Maria, Giuffrida, Enrica, Privitera, Antonino Carlo, Piccillo, Giovita, Magnano, Antonio, Vinci, Elisa, Vassallo, Roberto, Trovatello, Antonino, Belluardo, Nunzio, Giangreco, Emiliano, Camilleri, Salvatore, Garufi, Serena, Bertolami, Carmelo, Ventimiglia, Marco, Renna, Sara, Orlando, Rosalba, Rizzuto, Giulia, Orlando, Ambrogio

Volltext

The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including188ltiple Switches von Macaluso, Fabio Salvatore, Fries, Walter, Viola, Anna, Centritto, Andrea, Cappello, Maria, Giuffrida, Enrica, Privitera, Antonino Carlo, Piccillo, Giovita, Magnano, Antonio, Vinci, Elisa, Vassallo, Roberto, Trovatello, Antonino, Belluardo, Nunzio, Giangreco, Emiliano, Camilleri, Salvatore, Garufi, Serena, Bertolami, Carmelo, Ventimiglia, Marco, Renna, Sara, Orlando, Rosalba, Rizzuto, Giulia, Orlando, Ambrogio

Volltext

A Propensity Score-matched Comparison of Infliximab and Adalimumab in Tumour Necrosis Factor-α Inhibitor-naïve and Non-naïve Patients With Crohn’s Disease: Real-Life Data From the... von Macaluso, Fabio Salvatore, Fries, Walter, Privitera, Antonio Carlo, Cappello, Maria, Siringo, Sebastiano, Inserra, Gaetano, Magnano, Antonio, Di Mitri, Roberto, Mocciaro, Filippo, Belluardo, Nunzio, Scarpulla, Giuseppe, Magrì, Giovanni, Trovatello, Antonino, Carroccio, Antonio, Genova, Salvatore, Bertolami, Carmelo, Vassallo, Roberto, Romano, Claudio, Citrano, Michele, Accomando, Salvatore, Ventimiglia, Marco, Renna, Sara, Orlando, Rosalba, Rizzuto, Giulia, Porcari, Serena, Ferracane, Concetta, Cottone, Mario, Orlando, Ambrogio

Volltext